Microbiology Insider

Dear Microbiology Insider,

Next-generation sequencing (NGS) is changing the face of clinical diagnostics, offering a way to replace many conventional lab tests with technology that has a wide range of clinical applications.

But that performance comes at a price. NGS systems aren't cheap, with the combination of hardware and software costing several hundred thousand dollars. Contributing writer Joe Constance takes a look at the cost-benefit analysis of NGS in a new article in the Microbiology Community.

Also, the annual meeting of the American Association for Clinical Chemistry (AACC) is coming up later this month in Atlanta -- unfortunately at the same time that the southeastern U.S. finds itself in the grips of a COVID-19 outbreak. The AACC has been steadily strengthening its vaccination and testing requirements for attendees. Get the latest on the group's requirements.

In other news in the community:

Get these stories and more in your Microbiology Community!

Page 1 of 2
Next Page